Genetics

Optic neuritis is often the first clinical manifestation of multiple sclerosis (MS), yet predicting which patients will ultimately develop the disease remains a major clinical challenge. Recent research published in Nature Communications demonstrates that integrating polygenic risk scores with demographic information can significantly improve the prediction of MS in individuals presenting with optic neuritis. By analyzing large-scale genomic and clinical datasets, including the UK Biobank and independent validation cohorts, the study shows that genetic susceptibility plays a measurable role in determining disease progression. These findings highlight the growing importance of genomics in neurological diagnostics and suggest that genetic risk stratification may help clinicians identify high-risk patients earlier, enabling more personalized monitoring and treatment strategies.